White Paper

How Actigraphy Is Clearing Operational Barriers To Decentralized Trials

Source: ActiGraph
Barrier

Wearable-enabled decentralized clinical trials (DCTs) are transforming drug development by empowering patients to participate from home, reducing the burdens on participants, and expanding the opportunities to collect data. Yet, operational challenges are impeding efforts to realize those benefits. Faced with those barriers, sponsors are turning to proven systems for collecting real-world data to support their DCTs.

Interest in DCTs is underpinned by a recognition of the clear advantages of allowing trial participants to report data directly from home. Notably, DCTs loosen, and in some cases sever, the tie between geographic proximity to sites and willingness to participate in clinical trials. Of all the structural and clinical barriers to research participation, a lack of access to studies is by far the biggest obstacle.1 Geography is central to the problem, with 67% of oncologists being unlikely to refer participants who live two hours from a site.2

VIEW THE WHITE PAPER!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader